You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study

 

Online download statistics by month:

Online download statistics by month: November 2023 to August 2024

AbstractFullPdf
Nov 2023412018
Dec 2023141019
Jan 20247609
Feb 202410807
Mar 2024186016
Apr 2024132014
May 2024140010
Jun 2024148025
Jul 2024178010
Aug 2024160022
Total16810150